BIOREGENX, INC. Quarterly Debt-to-equity in % from Q3 2023 to Q2 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Bioregenx, Inc. quarterly Debt-to-equity history and growth rate from Q3 2023 to Q2 2025.
Bioregenx, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 557 %, a 1211% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2025	557	+515	+1211%	Jun 30, 2025
Q1 2025	73.9	-17.1	-18.8%	Mar 31, 2025
Q4 2024	37.7	+74.7		Dec 31, 2024
Q3 2024	34.2	+43.6		Sep 30, 2024
Q2 2024	42.5			Jun 30, 2024
Q1 2024	91			Mar 31, 2024
Q4 2023	-37			Dec 31, 2023
Q3 2023	-9.43			Sep 30, 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.